Literature DB >> 31486115

Exercise in multiple sclerosis and its models: Focus on the central nervous system outcomes.

Ling Yi Guo1,2,3, Brian Lozinski2,3, Voon Wee Yong2,3.   

Abstract

Multiple sclerosis (MS) is a central nervous system (CNS) disorder characterized by inflammation, demyelination, and neurodegeneration. Emerging research suggests that exercise has therapeutic benefits for MS patients but the clinical data have focused primarily on non-CNS outcomes. In this review, we discuss evidence in preclinical MS models that exercise influences oligodendrocyte proliferation and repopulation, remyelination, neuroinflammation, neuroprotection, axonal regeneration, and astrogliosis. Evidence for the therapeutic effects of exercise in MS is further supplemented by data from other CNS diseases, including Alzheimer's disease, Parkinson's disease, and spinal cord injury. These results motivate studies into the benefits that exercise confers within the CNS in MS.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  neuroinflammation; neuroprotection; oligodendrocytes; physical activity; remyelination

Mesh:

Year:  2019        PMID: 31486115     DOI: 10.1002/jnr.24524

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Aerobic training improves blood-brain barrier and neuronal apoptosis in experimental autoimmune encephalomyelitis.

Authors:  Omid Razi; Abdolhossein Parnow; Iraj Rashidi; Nafiseh Pakravan; Seyed Ershad Nedaei; Robert W Motl
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

2.  Exercise rapidly alters proteomes in mice following spinal cord demyelination.

Authors:  Brian Mark Lozinski; Luiz Gustavo Nogueira de Almeida; Claudia Silva; Yifei Dong; Dennis Brown; Sameeksha Chopra; V Wee Yong; Antoine Dufour
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

3.  Staying Strong Toolbox: Co-design of a physical activity and lifestyle program for Aboriginal families with Machado-Joseph disease in the Top End of Australia.

Authors:  Jennifer J Carr; Joyce Lalara; Gayangwa Lalara; Gwen Lalara; Bronwyn Daniels; Alan R Clough; Anne Lowell; Ruth N Barker
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

Review 4.  Preventing Multiple Sclerosis: The Pediatric Perspective.

Authors:  Duriel Hardy; Tanuja Chitnis; Emmanuelle Waubant; Brenda Banwell
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

5.  The influence of COVID-19 pandemic lockdown on the physical activity of people with multiple sclerosis. The role of online training.

Authors:  Mariola Matysiak; Małgorzata Siger; Agata Walczak; Agnieszka Ciach; Mateusz Jonakowski; Mariusz Stasiołek
Journal:  Mult Scler Relat Disord       Date:  2022-05-06       Impact factor: 4.808

6.  Effects of different physical activities on brain-derived neurotrophic factor: A systematic review and bayesian network meta-analysis.

Authors:  Bojun Zhou; Zhisheng Wang; Lianghao Zhu; Gang Huang; Bing Li; Chaofan Chen; Junda Huang; Fuhai Ma; Timon Chengyi Liu
Journal:  Front Aging Neurosci       Date:  2022-08-26       Impact factor: 5.702

Review 7.  Strategies and prospects of effective neural circuits reconstruction after spinal cord injury.

Authors:  Biao Yang; Feng Zhang; Feng Cheng; Liwei Ying; Chenggui Wang; Kesi Shi; Jingkai Wang; Kaishun Xia; Zhe Gong; Xianpeng Huang; Cao Yu; Fangcai Li; Chengzhen Liang; Qixin Chen
Journal:  Cell Death Dis       Date:  2020-06-08       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.